Search company, investor...

OsteoGeneX

osteogenex.com

About OsteoGeneX

Developer of novel therapeutics to modulate the growth of bone and cancer. The company develops therapeutics based on the sclerostin (SOST) family and focused primarily on building new bone. [Keywords: bone morphogenetic proteins (BMPs), osteoporosis]

Headquarters Location

2002 West 39th Street

Kansas City, Kansas, 66160,

United States

(913)945-6763

Loading...

Loading...

OsteoGeneX Patents

OsteoGeneX has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/30/2009

6/12/2012

Vinpocetine and eburn amonine derivatives for promoting bone growth

Rare diseases, Skeletal system, Clusters of differentiation, Orthopedic surgical procedures, Osteopathies

Grant

Application Date

6/30/2009

Grant Date

6/12/2012

Title

Vinpocetine and eburn amonine derivatives for promoting bone growth

Related Topics

Rare diseases, Skeletal system, Clusters of differentiation, Orthopedic surgical procedures, Osteopathies

Status

Grant

OsteoGeneX Frequently Asked Questions (FAQ)

  • Where is OsteoGeneX's headquarters?

    OsteoGeneX's headquarters is located at 2002 West 39th Street, Kansas City.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.